SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    F. Ponchel, V. Goeb, R. Parmar, Y. El-Sherbiny, M. Boissinot, J. El Jawhari, A. Burska, E. M. Vital, S. Harrison, P. G. Conaghan, E. Hensor, P. Emery, An immunological biomarker to predict MTX response in early RA, Annals of the Rheumatic Diseases, 2014, 73, 11, 2047

    CrossRef

  2. 2
    María Victoria Martire, Lucila Marino Claverie, Vanesa Duarte, Anastasia Secco, Marta Mammani, Factores asociados a remisión sostenida en pacientes con artritis reumatoide, Reumatología Clínica, 2014,

    CrossRef

  3. 3
    Manuelle Viguier, Cristina Livideanu, Marie Beylot-Barry, Marie-Aleth Richard, Carle Paul, Hervé Bachelez, François Aubin, Observational case series on a group of psoriasis patients who failed to respond to any TNF blockers, Journal of Dermatological Treatment, 2014, 25, 1, 75

    CrossRef

  4. 4
    Fabiola Atzeni, Sara Bongiovanni, Antonio Marchesoni, Matteo Filippini, Roberto Caporali, Roberto Gorla, Lorenzo Cavagna, Ennio-Giulio Favalli, Francesco Saccardo, Piercarlo Sarzi-Puttini, Prédicteurs de la réponse aux traitements anti-TNF chez les patients ayant une polyarthrite rhumatoïde avec des scores DAS28 modérés ou élevés, Revue du Rhumatisme, 2014, 81, 1, 54

    CrossRef

  5. 5
    Fabiola Atzeni, Sara Bongiovanni, Antonio Marchesoni, Matteo Filippini, Roberto Caporali, Roberto Gorla, Lorenzo Cavagna, Ennio Giulio Favalli, Francesco Saccardo, Piercarlo Sarzi-Puttini, Predictors of response to anti-TNF therapy in RA patients with moderate or high DAS28 scores, Joint Bone Spine, 2014, 81, 1, 37

    CrossRef

  6. 6
    P. M. ten Klooster, H. E. Vonkeman, M. A. H. Oude Voshaar, L. Siemons, P. L. C. M. van Riel, M. A. F. J. van de Laar, Predictors of satisfactory improvements in pain for patients with early rheumatoid arthritis in a treat-to-target study, Rheumatology, 2014,

    CrossRef

  7. 7
    Guan-Ying Wang, Sa-Li Zhang, Xiu-Ru Wang, Min Feng, Chun Li, Yuan An, Xiao- Feng Li, Li-Zhi Wang, Cai-Hong Wang, Yong-Fu Wang, Rong Yang, Hui-Ming Yan, Guo-Chun Wang, Xin Lu, Xia Liu, Ping Zhu, Li-Na Chen, Hong-Tao Jin, Jin-Ting Liu, Hui-Fang Guo, Hai-Ying Chen, Jian-Li Xie, Ping Wei, Jun-Xiang Wang, Xiang-Yuan Liu, Lin Sun, Liu-Fu Cui, Rong Shu, Bai-Lu Liu, Ping Yu, Zhuo-Li Zhang, Guang-Tao Li, Zhen-Bin Li, Jing Yang, Jun-Fang Li, Bin Jia, Feng-Xiao Zhang, Jie-Mei Tao, Jin-Ying Lin, Mei-Qiu Wei, Xiao-Min Liu, Dan Ke, Shao-Xian Hu, Cong Ye, Shu-Ling Han, Xiu-Yan Yang, Hao Li, Ci-Bo Huang, Ming Gao, Bei Lai, Yong-Jing Cheng, Xing-Fu Li, Li-Jun Song, Xiao-Xia Yu, Ai-Xue Wang, Li-Jun Wu, Yan-Hua Wang, Lan He, Wen-Wen Sun, Lu Gong, Xiao-Yuan Wang, Yi Wang, Yi Zhao, Xiao-Xia Li, Yan Wang, Yan Zhang, Yin Su, Chun-Fang Zhang, Rong Mu, Zhan-Guo Li, Remission of rheumatoid arthritis and potential determinants: a national multi-center cross-sectional survey, Clinical Rheumatology, 2014,

    CrossRef

  8. 8
    Antonio Naranjo, Ana Bilbao, Celia Erausquin, Soledad Ojeda, Félix M. Francisco, Iñigo Rúa-Figueroa, Carlos Rodríguez-Lozano, Results of a specific smoking cessation program for patients with arthritis in a rheumatology clinic, Rheumatology International, 2014, 34, 1, 93

    CrossRef

  9. 9
    Yue Shen, Shizhou Yang, Zhongli Shi, Tiao Lin, Hanxiao Zhu, Fanggang Bi, An Liu, Xiaozhou Ying, Haixiao Liu, Kehe Yu, Shigui Yan, SeMet Mediates Anti-inflammation in LPS-Induced U937 Cells Targeting NF-κB Signaling Pathway, Inflammation, 2014,

    CrossRef

  10. 10
    A. Naranjo, N. A. Khan, M. Cutolo, S.-S. Lee, J. Lazovskis, K. Laas, S. Pandya, T. Sokka, Smoking cessation advice by rheumatologists: results of an international survey, Rheumatology, 2014, 53, 10, 1825

    CrossRef

  11. 11
    N. Takahashi, T. Kojima, A. Kaneko, D. Kida, Y. Hirano, T. Fujibayashi, Y. Yabe, H. Takagi, T. Oguchi, H. Miyake, T. Kato, N. Fukaya, M. Hayashi, S. Tsuboi, Y. Kanayama, K. Funahashi, M. Hanabayashi, S. Hirabara, S. Asai, Y. Yoshioka, N. Ishiguro, Use of a 12-week observational period for predicting low disease activity at 52 weeks in RA patients treated with abatacept: a retrospective observational study based on data from a Japanese multicentre registry study, Rheumatology, 2014,

    CrossRef

  12. 12
    Cristina Pomirleanu, Codrina Ancuta, Smaranda Miu, Rodica Chirieac, A predictive model for remission and low disease activity in patients with established rheumatoid arthritis receiving TNF blockers, Clinical Rheumatology, 2013, 32, 5, 665

    CrossRef

  13. 13
    M. C. F. J. Rotte, P. H. P. Jong, S. M. F. Pluijm, M. Bulatović Ćalasan, P. J. Barendregt, D. Zeben, P. A. Lubbe, P. B. Sonnaville, J. Lindemans, J. M. W. Hazes, R. Jonge, Association of Low Baseline Levels of Erythrocyte Folate With Treatment Nonresponse at Three Months in Rheumatoid Arthritis Patients Receiving Methotrexate, Arthritis & Rheumatism, 2013, 65, 11
  14. 14
    Sofia Ajeganova, Maria L. Andersson, Ingiäld Hafström, Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: A long-term followup from disease onset, Arthritis Care & Research, 2013, 65, 1
  15. 15
    T Tiippana-Kinnunen, H Kautiainen, L Paimela, M Leirisalo-Repo, Co-morbidities in Finnish patients with rheumatoid arthritis: 15-year follow-up, Scandinavian Journal of Rheumatology, 2013, 42, 6, 451

    CrossRef

  16. 16
    Licia Maria Henrique da Mota, Bóris Afonso Cruz, Claiton Viegas Brenol, Ivânio Alves Pereira, Lucila Stange Rezende-Fronza, Manoel Barros Bertolo, Max Vitor Carioca Freitas, Nilzio Antônio da Silva, Paulo Louzada-Junior, Rina Dalva Neubarth Giorgio, Rodrigo Aires Corrêa Lima, Wanderley Marques Bernardo, Geraldo da Rocha Castelar Pinheiro, Diretrizes para o tratamento da artrite reumatoide, Revista Brasileira de Reumatologia, 2013, 53, 2, 158

    CrossRef

  17. 17
    Maria L E Andersson, Björn Svensson, Ingemar F Petersson, Ingiäld Hafström, Kristina Albertsson, Kristina Forslind, Dick Heinegård, Tore Saxne, Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis, BMC Musculoskeletal Disorders, 2013, 14, 1, 229

    CrossRef

  18. 18
    Licia Maria Henrique da Mota, Bóris Afonso Cruz, Claiton Viegas Brenol, Ivânio Alves Pereira, Lucila Stange Rezende-Fronza, Manoel Barros Bertolo, Max Vitor Carioca Freitas, Nilzio Antônio da Silva, Paulo Louzada-Junior, Rina Dalva Neubarth Giorgio, Rodrigo Aires Corrêa Lima, Wanderley Marques Bernardo, Geraldo da Rocha Castelar Pinheiro, Guidelines for the drug treatment of rheumatoid arthritis, Revista Brasileira de Reumatologia (English Edition), 2013, 53, 2, 158

    CrossRef

  19. 19
    Varun Dhir, Amit Sandhu, Nidhi Gupta, Veena Dhawan, Shefali Sharma, Aman Sharma, Low Serum Levels of Myeloid Progenitor Inhibitory Factor-1 Predict Good Response to Methotrexate in Rheumatoid Arthritis, ISRN Inflammation, 2013, 2013, 1

    CrossRef

  20. 20
    Ernest H. Choy, Arthur F. Kavanaugh, Simon A. Jones, The problem of choice: current biologic agents and future prospects in RA, Nature Reviews Rheumatology, 2013, 9, 3, 154

    CrossRef

  21. 21
    Lara Valor, Inmaculada de la Torre Ortega, ¿Debemos usar los factores de mal pronóstico para iniciar precozmente un tratamiento biológico en los pacientes con artritis reumatoide?, Reumatología Clínica, 2012, 8, 4, 163

    CrossRef

  22. 22
    Antonio Naranjo, Ana Bilbao, César García de Llanos, Advice by the Rheumatologist on Quitting Smoking: Are We Doing Well With Smokers?, Reumatología Clínica (English Edition), 2012, 8, 3, 160

    CrossRef

  23. 23
    Antonio Naranjo, Ana Bilbao, César García de Llanos, Consejo del reumatólogo sobre deshabituación tabáquica: ¿estamos actuando adecuadamente con los pacientes fumadores?, Reumatología Clínica, 2012,

    CrossRef

  24. 24
    Stefan Kleinert, Hans-Peter Tony, Andreas Krause, Martin Feuchtenberger, Siegfried Wassenberg, Constanze Richter, Ekkehard Röther, Wolfgang Spieler, Holger Gnann, Bianca M. Wittig, Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study, Rheumatology International, 2012, 32, 9, 2759

    CrossRef

  25. 25
    Karina I. Halilova, Elizabeth E. Brown, Sarah L. Morgan, S. Louis Bridges, Min-Ho Hwang, Donna K. Arnett, Maria I. Danila, Markers of Treatment Response to Methotrexate in Rheumatoid Arthritis: Where Do We Stand?, International Journal of Rheumatology, 2012, 2012, 1

    CrossRef

  26. 26
    Lara Valor, Inmaculada de la Torre Ortega, Should We Use Poor Prognosis Factors to Start Early Treatment in Patients With Rheumatoid Arthritis?, Reumatología Clínica (English Edition), 2012, 8, 4, 163

    CrossRef

  27. 27
    Damini Jawaheer, Susan Messing, George Reed, Veena K. Ranganath, Joel M. Kremer, James S. Louie, Dinesh Khanna, Jeffrey D. Greenberg, Daniel E. Furst, Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of north america cohort of rheumatoid arthritis patients, Arthritis Care & Research, 2012, 64, 12
  28. 28
    SJ Park, JI Shin, The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug: comments on the article by Söderlin et al, Scandinavian Journal of Rheumatology, 2012, 41, 5, 411

    CrossRef

  29. 29
    Montserrat Robustillo Villarino, Jesús Rodríguez Moreno, ¿Son útiles los factores pronóstico en la artritis reumatoide?, Reumatología Clínica, 2011, 7, 5, 339

    CrossRef

  30. 30
    Montserrat Robustillo Villarino, Jesús Rodríguez Moreno, Are Prognostic Factors Useful in Rheumatoid Arthritis?, Reumatología Clínica (English Edition), 2011, 7, 5, 339

    CrossRef

  31. 31
    Suleyman Önal, Mustafa Nazıroğlu, Mesut Çolak, Vedat Bulut, Manuel F. Flores-Arce, Effects of Different Medical Treatments on Serum Copper, Selenium and Zinc Levels in Patients with Rheumatoid Arthritis, Biological Trace Element Research, 2011, 142, 3, 447

    CrossRef

  32. 32
    László Maródi, Jean-Laurent Casanova, Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments, Journal of Allergy and Clinical Immunology, 2010, 126, 5, 910

    CrossRef